- Petronas Chemicals reported a loss per share of 4.0 sen for the third quarter.
- Analysts had estimated an earnings per share (EPS) of 2.1 sen, based on 2 forecasts.
- The company announced a net loss amounting to 289.0 million ringgit during the period.
- The revenue for the third quarter was recorded at 6.79 billion ringgit.
- In terms of stock recommendations, there are 5 buy ratings, 4 hold ratings, and 12 sell ratings.
A look at Petronas Chemicals Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking ahead, the long-term outlook for Petronas Chemicals Group Bhd is positive, as indicated by its Smart Scores across different factors. The company scores well in terms of value, reflecting its perceived attractiveness as an investment opportunity. While its dividend score is slightly lower, indicating room for improvement, Petronas Chemicals Group shows promising signs in terms of growth potential, resilience, and momentum. These scores suggest a balanced outlook for the company’s future performance.
Petronas Chemicals Group Bhd, a chemical company, provides a wide range of petrochemical products including olefins, polymers, fertilisers, methanol, and basic chemicals. Despite facing some challenges, the company’s overall Smart Scores reflect a favorable outlook on its value, growth potential, resilience, and momentum. With a solid foundation in the chemical industry, Petronas Chemicals Group is poised to capitalize on opportunities for sustained growth and profitability in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
